Author:
Carmichael Josie,Fadavi Hassan,Ishibashi Fukashi,Shore Angela C.,Tavakoli Mitra
Abstract
The incidence of both type 1 and type 2 diabetes is increasing worldwide. Diabetic peripheral neuropathy (DPN) is among the most distressing and costly of all the chronic complications of diabetes and is a cause of significant disability and poor quality of life. This incurs a significant burden on health care costs and society, especially as these young people enter their peak working and earning capacity at the time when diabetes-related complications most often first occur. DPN is often asymptomatic during the early stages; however, once symptoms and overt deficits have developed, it cannot be reversed. Therefore, early diagnosis and timely intervention are essential to prevent the development and progression of diabetic neuropathy. The diagnosis of DPN, the determination of the global prevalence, and incidence rates of DPN remain challenging. The opinions vary about the effectiveness of the expansion of screenings to enable early diagnosis and treatment initiation before disease onset and progression. Although research has evolved over the years, DPN still represents an enormous burden for clinicians and health systems worldwide due to its difficult diagnosis, high costs related to treatment, and the multidisciplinary approach required for effective management. Therefore, there is an unmet need for reliable surrogate biomarkers to monitor the onset and progression of early neuropathic changes in DPN and facilitate drug discovery. In this review paper, the aim was to assess the currently available tests for DPN’s sensitivity and performance.
Subject
Endocrinology, Diabetes and Metabolism
Reference206 articles.
1. Chapter 4 - Diabetes: Key Markers of Injury and Prognosis;Neeland,2019
2. Brussels, BelgiumInternational Diabetes FederationIDF Diabetes Atlas2019
3. London, UKDiabetes UKUs, diabetes and a lot of facts and stats2019
4. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes;Hicks;Curr Diabetes Rep,2019
5. Diabetic Neuropathy: A Position Statement by the American Diabetes Association;Pop-Busui;Diabetes Care,2017
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献